For the Inventor, By the Inventor

Enter inventor name

Zhejiang, China

Xiaohong Sheng

USPTO Granted Patents = 28

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 19(Granted Patents)

Location History:

Hangzhou, CN (2015 - 2020)
Zhejiang, CN (2018 - 2024)

Company Filing History:

Hangzhou Solipharma Co., Ltd.

Hangzhou Pushai Pharmaceutical Technology Co., Ltd.

Hangzhou Pushai Pharmaceutical Technology

Hangzhou Pushai Pharmaeutical Technology Co., Ltd.

Years Active: 2015-2024

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12103925 - Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereof (2024-10-01),

2. 11919906 - Crystal form of ACP-196 and method of treatment thereof (2024-03-05),

3. 11639341 - Crystal form of tipifarnib and method of treatment thereof (2023-05-02),

4. 11427528 - Fenofibrate crystalline form and manufacturing method thereof (2022-08-30),

5. 11286259 - Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof (2022-03-29),

6. 11236077 - Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof (2022-02-01),

7. 11236073 - ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof (2022-02-01),

8. 11208382 - Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof (2021-12-28),

9. 11117875 - Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod (2021-09-14),

10. 11111248 - Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof (2021-09-07),

11. 10995083 - Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition (2021-05-04),

12. 10954223 - Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof (2021-03-23),

13. 10954210 - Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof (2021-03-23),

14. 10899770 - Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof (2021-01-26),

15. 10899767 - Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereof (2021-01-26),

Title: Xiaohong Sheng: Pioneering Inventor from Zhejiang, CN

Introduction: Xiaohong Sheng is a trailblazing inventor hailing from the vibrant province of Zhejiang, China. With a passion for innovation and a keen eye for detail, she has made significant contributions to the field of technology through her groundbreaking inventions.

Latest Patents: Xiaohong Sheng holds several patents in various technological domains, showcasing her versatility and ingenuity in creating novel solutions to complex problems. Her latest patents focus on cutting-edge advancements in artificial intelligence and sustainable energy technologies.

Career Highlights: Throughout her illustrious career, Xiaohong Sheng has garnered recognition for her innovative spirit and dedication to pushing the boundaries of technological advancement. Her work has not only revolutionized industries but has also inspired a new generation of inventors to pursue their creative aspirations.

Collaborations: Xiaohong Sheng has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. By fostering strong partnerships and sharing her expertise, she has been able to amplify the impact of her innovations on a global scale.

Conclusion: Xiaohong Sheng's remarkable journey as an inventor exemplifies the power of perseverance, creativity, and collaboration in driving meaningful change in the world of technology. Her pioneering spirit continues to inspire and shape the future of innovation, making her a true visionary in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…